The A-share weight-loss drug sector saw a significant correction, with Changshan Pharmaceutical hitting its daily limit down, and other companies such as Shengnuo Bio, Zhaoyan New Drug, Borui Pharmaceutical, Lepu Medical, Hanyu Pharmaceutical, and Gan & Lee Pharmaceutical following suit.